NO912942L - VACCINE FOR PREVENTIVE TREATMENT OF INFECTION OF LIVERABILITY OF DRUGS. - Google Patents

VACCINE FOR PREVENTIVE TREATMENT OF INFECTION OF LIVERABILITY OF DRUGS.

Info

Publication number
NO912942L
NO912942L NO91912942A NO912942A NO912942L NO 912942 L NO912942 L NO 912942L NO 91912942 A NO91912942 A NO 91912942A NO 912942 A NO912942 A NO 912942A NO 912942 L NO912942 L NO 912942L
Authority
NO
Norway
Prior art keywords
vaccine
infection
liverability
drugs
preventive treatment
Prior art date
Application number
NO91912942A
Other languages
Norwegian (no)
Other versions
NO912942D0 (en
Inventor
Sonia Louise Crameri
Michael Panaccio
Lachlan Robert Wilson
Gene Louise Wijffels
Terence William Spithill
Noel John Campbell
Catriona Mary Thompson
Jennifer Louise Sexton
Andrew Richard Milner
Graham Frank Mitshell
Original Assignee
Daratech Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daratech Pty Ltd filed Critical Daratech Pty Ltd
Publication of NO912942D0 publication Critical patent/NO912942D0/en
Publication of NO912942L publication Critical patent/NO912942L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1088—Glutathione transferase (2.5.1.18)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Vaksine for forebyggende behandling mot infeksjon av leverikte hos drøvtyggere, hvor antigenet er glutation- S-transferase ekstrahert fra voksne ormer fra F. hepatica. Antigenet kan også være syntetisk ekvivalente molekyler og ekvivalente molekyler fremstilt ved rekombinante DNA-teknikker. Metoder for fremstilling er også beskrevet.Vaccine for prophylactic treatment of hepatic infection in ruminants, where the antigen is glutathione S-transferase extracted from adult worms from F. hepatica. The antigen may also be synthetically equivalent molecules and equivalent molecules prepared by recombinant DNA techniques. Methods of preparation are also described.

NO91912942A 1989-01-31 1991-07-29 VACCINE FOR PREVENTIVE TREATMENT OF INFECTION OF LIVERABILITY OF DRUGS. NO912942L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ248189 1989-01-31
PCT/AU1990/000027 WO1990008819A1 (en) 1989-01-31 1990-01-31 Vaccine for the preventative treatment of infection of liver fluke in ruminants

Publications (2)

Publication Number Publication Date
NO912942D0 NO912942D0 (en) 1991-07-29
NO912942L true NO912942L (en) 1991-09-26

Family

ID=3773671

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912942A NO912942L (en) 1989-01-31 1991-07-29 VACCINE FOR PREVENTIVE TREATMENT OF INFECTION OF LIVERABILITY OF DRUGS.

Country Status (8)

Country Link
EP (1) EP0456662A4 (en)
JP (1) JPH04507235A (en)
AU (1) AU634754B2 (en)
BR (1) BR9007070A (en)
CA (1) CA2045663A1 (en)
NO (1) NO912942L (en)
NZ (1) NZ232327A (en)
WO (1) WO1990008819A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657883A1 (en) * 1990-02-07 1991-08-09 Transgene Sa
GB9018238D0 (en) * 1990-08-20 1990-10-03 Trudgett Alan G Liver fluke diagnostic system
ES2199947T3 (en) * 1992-10-21 2004-03-01 John Pius Dalton VACCINE CONTAINING A TIOLPROTEASE.
WO1994017820A1 (en) * 1993-02-05 1994-08-18 Daratech Pty. Ltd. Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same
EP0721466A1 (en) * 1993-09-28 1996-07-17 The University Of Melbourne Protective antigens against parasites
CN1068334C (en) * 1994-06-08 2001-07-11 北京医科大学 Schistosome vaccine peptide No.2
CN1061990C (en) * 1994-06-08 2001-02-14 北京医科大学 Schistosome vaccine peptide No.1
CN1061991C (en) * 1994-06-08 2001-02-14 北京医科大学 Schistosome vaccine peptide NO.3
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
CN105903007A (en) * 2016-06-15 2016-08-31 青海大学 Design and preparation method and application of novel fasciola hepatica multi-epitope vaccine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
NZ224663A (en) * 1987-05-28 1990-11-27 Amrad Corp Ltd Fusion proteins containing glutathione-s-transferase and expression of foreign polypeptides using glutathione-s-transferase encoding vectors

Also Published As

Publication number Publication date
EP0456662A4 (en) 1991-12-11
AU634754B2 (en) 1993-03-04
CA2045663A1 (en) 1990-08-01
EP0456662A1 (en) 1991-11-21
NZ232327A (en) 1993-02-25
WO1990008819A1 (en) 1990-08-09
AU5028390A (en) 1990-08-24
NO912942D0 (en) 1991-07-29
BR9007070A (en) 1991-11-12
JPH04507235A (en) 1992-12-17

Similar Documents

Publication Publication Date Title
Youn et al. Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis.
ATE126706T1 (en) SKIN TEST AND TEST KIT FOR AIDS.
NO933126D0 (en) RELIABLE LIGANDS FOR CD40
ATE182271T1 (en) MEDICINAL PRODUCTS FOR THE TREATMENT OF CANCER, AIDS AND VIRUS DISEASES
GR3005768T3 (en)
FI913943A0 (en) NYA KROMAN- OCH THIOCHROMANDERS.
NO912942L (en) VACCINE FOR PREVENTIVE TREATMENT OF INFECTION OF LIVERABILITY OF DRUGS.
DE68907679D1 (en) ACID-RESISTANT FIBROBLAST GROWTH FACTOR, PREPARATION FOR TREATING STOMESTIC ARROW DISEASES.
FI882707A7 (en) Method and preparation for increasing the protein content of milk.
EP0313378A3 (en) Methods and compositions for transient elimination of humoral immune antibodies
ATE179614T1 (en) HERPES SIMPLEX VIRUS VP16 VACCINES
ATE243750T1 (en) LEISHMANIA ANTIGENS FOR USE IN LEISHMANIASIS THERAPY AND DIAGNOSIS
ATE130198T1 (en) PREPARATION OF A VIRUS AND PURIFICATION OF VIRUS COATING PROTEINS FOR VACCINE USE.
ATE222930T1 (en) ANTIGENIC DRUG FOR TREATMENT OR PREVENTION
IL105119A0 (en) Immunoglobins and antigens for the treatment of staphylococcus infections,methods for the identification and preparation thereof and pharmaceutical compositions containing the same
ATE237691T1 (en) RECOMBINANT CAT INFECTIOUS PERITONITIS SMALLVIRUS, COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREOF
ATE136468T1 (en) VACCINE FOR TREATING HSV
DK0484438T3 (en) Biological preparation and its use
ES2044170T3 (en) STRONTIUM SALT, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT.
DE3750886D1 (en) Use of an immunoglobulin-containing preparation for the prophylaxis and therapy of AIDS in humans.
EP0251460A3 (en) Method for producing hepatitis b virus core antigen (hbcag) in yeast
Tu et al. Comparison of Naja naja siamensis and Naja naja atra venoms
ES2060440T3 (en) DERIVATIVES OF 1,4-DIHIDROPIRIDIN-DICARBOXILICOS ACIDS ARIL-QUINOLIL SUBSTITUTED, PROCEDURE FOR ITS MANUFACTURE AND ITS USE IN MEDICINES.
DE3784513D1 (en) HUMAN B-LYMPHOTROPER VIRUS (HBLV), INSULATION AND PRODUCTS.
Gerenčer et al. Immunosuppression of in vivo and in vitro lymphocyte responses in swine induced by Trichinella spiralis or excretory-secretory antigens of the parasite